Lactose (India) (LACTOSE): Lactose India Share Price Falls 11.50% to Rs 92.35 as Micro Cap Stock Declines
- November 16, 2026
- Posted by: Kunal Singla
- Category: News
Lactose India Share Price fell 11.50% on 16 November 2026, with the stock trading at Rs 92.35 against a previous close of Rs 104.35 as of 16 November 2026 at 11:38:00 AM IST. The decline of Rs 12.00 leaves the Micro Cap Pharmaceuticals & Drugs company with a market capitalisation of Rs 131.37 crore, and it has made Lactose India stock news for market watchers today.
This Lactose India Share Price fall is the event Univest is tracking in today’s market update. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. What readers can verify is the price action and the company’s financial ratios, which show a P/E ratio of 18.96, a P/B ratio of 2.17, ROE of 10.98% and ROCE of 11.35%.
Anyone following Lactose India Share Price Today should keep an eye on the day range of Rs 89.90 to Rs 102.15 and on how the valuation compares with Pharmaceuticals & Drugs peers. Both points are covered in the sections below, along with sector benchmarks, company context and answers to common questions.
Lactose (India) (LACTOSE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 92.35 |
| Previous Close | Rs 104.35 |
| Today's Move | -Rs 12.00 (-11.5%) |
| Open | Rs 100.35 |
| High | Rs 102.15 |
| Low | Rs 89.9 |
| Market Capitalisation | Rs 131.37 crore |
| Market Cap Category | Micro Cap |
Lactose India Share Price Today stands at Rs 92.35, down Rs 12.00 or 11.50% from the previous close of Rs 104.35. The stock opened at Rs 100.35, touched a high of Rs 102.15 and a low of Rs 89.90 as of 16 November 2026 at 11:38:00 AM IST.
The opening price of Rs 100.35 was already Rs 4.00 below the previous close. From there, the Lactose India Share Price first reached the day high of Rs 102.15, which is Rs 1.80 above the opening level, and then moved lower to the intraday low of Rs 89.90. The range between the high and the low is Rs 12.25, and at Rs 92.35 the stock is Rs 2.45 above the low and Rs 8.00 below its opening price.
The Lactose India share price fall comes for a company that Univest classifies as Micro Cap, with a market capitalisation of Rs 131.37 crore. Market capitalisation indicates company size rather than business quality, so the Lactose India stock performance today needs to be read alongside the financial ratios.
Readers checking the Lactose India Share Price Update should note the size of the move, the intraday range and the previous close of Rs 104.35 as the starting point. Those facts frame the fundamental picture covered next.
Lactose (India) (LACTOSE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 131.37 crore |
| P/E Ratio | 18.96x |
| P/B Ratio | 2.17x |
| ROE | 10.98% |
| ROCE | 11.35% |
| EPS | Rs 5.5 |
| Book Value Per Share | Rs 48.16 |
| Dividend Yield | 0% |
Lactose (India) (LACTOSE) fundamental metrics show P/E 18.96x, P/B 2.17x, ROE 10.98%, ROCE 11.35%. These figures provide context only and are not a buy or sell signal.
Lactose (India) has a market capitalisation of Rs 131.37 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.96x, P/B at 2.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.98% and ROCE of 11.35%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.5, book value per share of Rs 48.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 18.96x |
| Benchmark Median P/E | 30.93x |
| Benchmark Average P/E | 52.22x |
| Benchmark P/E Range | 2.6x to 1,177x |
| Company P/B Ratio | 2.17x |
| Benchmark Median P/B | 2.9x |
| Benchmark Average P/B | 3.43x |
| Company ROE | 10.98% |
| Benchmark Median ROE | 10.98% |
| Benchmark Average ROE | 4.7% |
| Company ROCE | 11.35% |
| Benchmark Median ROCE | 12.63% |
| Benchmark Average ROCE | 3.14% |
| Company Market Capitalisation | Rs 131.37 crore |
| Benchmark Median Market Cap | Rs 698.04 crore |
| Benchmark Average Market Cap | Rs 14,540.61 crore |
Lactose (India) (LACTOSE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Lactose (India) (LACTOSE) has a P/E ratio of 18.96x, which is below the benchmark median of 30.93x, a difference of -38.7%. On its own, the P/E gap is a valuation reference point, not a trading call.
Lactose (India) (LACTOSE) has a ROE of 10.98%, which is equal to the benchmark median of 10.98%, a difference of 0%. Lactose (India) (LACTOSE) has a ROCE of 11.35%, which is below the benchmark median of 12.63%, a difference of -10.13%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,51,290.91 | 41.15 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 3,05,014.11 | 90.7 | 16.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,77,333.2 | 83.49 | 9.65 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,30,755.56 | 97.59 | 21.57 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,18,802.71 | 28.42 | 4.27 | 19.69 | 21.39 |
Lactose (India) (LACTOSE) has a P/E ratio of 18.96x compared with the displayed peer median of 83.49x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 10.98% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 11.35% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Lactose (India) (LACTOSE) has a market capitalisation of Rs 131.37 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Lactose India
- Price action: Lactose India Share Price fell 11.50% to Rs 92.35 from a previous close of Rs 104.35.
- Day range: the stock moved between Rs 89.90 and Rs 102.15 as of 16 November 2026 at 11:38:00 AM IST.
- Valuation: a P/E of 18.96 and a P/B of 2.17 sit below the benchmark medians of 30.93 and 2.90.
- Returns: ROE of 10.98% matches the benchmark median of 10.98%, while ROCE of 11.35% sits below the median of 12.63%.
- Size: a market capitalisation of Rs 131.37 crore keeps the company in the Micro Cap category, below the industry median of Rs 698.04 crore.
About Lactose India
Lactose India Share Price relates to Lactose (India), which trades under the symbol LACTOSE and operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. This company overview places it among the smaller names of its same-industry benchmark of 205 companies, with a market capitalisation of Rs 131.37 crore against a benchmark median of Rs 698.04 crore. Univest groups it with Pharmaceuticals & Drugs companies such as Sun Pharmaceutical Industries and Zydus Lifesciences for benchmark purposes.
Track Lactose India Share Price on Univest
Use Lactose (India) (LACTOSE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Users can follow the Lactose India Share Price Live on Univest, along with fundamental ratios, 52-week levels and market insights in one place. The Univest stock page brings together the latest price, valuation multiples, return ratios and peer context, so readers can check the Lactose India Share Price Today and the company’s numbers without switching between sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Lactose India share price falling today?
Ans. Lactose India Share Price fell 11.50% to Rs 92.35 from a previous close of Rs 104.35. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. Its current market capitalisation is Rs 131.37 crore.
What is the Lactose India share price today?
Ans. Lactose India share price is Rs 92.35 as of 16 November 2026 at 11:38:00 AM IST. The stock opened at Rs 100.35, touched an intraday low of Rs 89.90 and is down Rs 12.00 from the previous close today.
What is the market capitalisation of Lactose India?
Ans. Lactose India Share Price reflects a market capitalisation of Rs 131.37 crore, which places the company in the Micro Cap category on Univest. The same-industry benchmark median is Rs 698.04 crore, so the company is smaller than the median.
What is the P/E ratio of Lactose India?
Ans. The P/E ratio behind the Lactose India Share Price is 18.96, against a same-industry benchmark median of 30.93 and an average of 52.22. The EPS is Rs 5.50, which shows the earnings attributable to each share of the company.
What are the ROE and ROCE of Lactose India?
Ans. Lactose India reports ROE of 10.98% and ROCE of 11.35% in the latest figures. The ROE matches the same-industry benchmark median of 10.98%, while the ROCE sits below the median of 12.63%, adding context to the Lactose India Share Price.
What is the book value of Lactose India?
Ans. Book value per share is Rs 48.16 and the P/B ratio is 2.17. Book value shows the accounting net worth behind each share, while P/B relates the current price directly to that figure. The same-industry benchmark P/B median is 2.90.
Does Lactose India pay a dividend?
Ans. Dividend yield for Lactose India is 0% in the latest figures. Dividend yield shows the historical payout relative to the current price and does not promise a future payout, so read it alongside the Lactose India Share Price.
How does Lactose India compare with its peers?
Ans. Against Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Laurus Labs and Zydus Lifesciences, Lactose India has a lower P/E and P/B than every peer, with ROE and ROCE also below all five and a much smaller market capitalisation.
Which sector does Lactose India belong to?
Ans. Lactose India belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Univest benchmarks it against 205 companies in its industry, where its P/E of 18.96 sits below the median of 30.93 and the average of 52.22.